Chemoinformaics analysis of 2-[3-(4-Hydroxyphenyl)propyl]-5-methoxyphenol
Molecular Weight | 258.317 | nRot | 5 |
Heavy Atom Molecular Weight | 240.173 | nRig | 12 |
Exact Molecular Weight | 258.126 | nRing | 2 |
Solubility: LogS | -3.13 | nHRing | 0 |
Solubility: LogP | 3.545 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
nHA | 3 | APOL | 41.1283 |
nHD | 2 | BPOL | 19.7937 |
QED | 0.865 |
Synth | 1.829 |
Natural Product Likeliness | 0.498 |
NR-PPAR-gamma | 0.323 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.076 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -4.79 |
MDCK | 0.0000161 |
BBB | 0.07 |
PPB | 0.979685 |
VDSS | 0.973 |
FU | 0.0160501 |
CYP1A2-inh | 0.977 |
CYP1A2-sub | 0.923 |
CYP2c19-inh | 0.961 |
CYP2c19-sub | 0.105 |
CYP2c9-inh | 0.826 |
CYP2c9-sub | 0.961 |
CYP2d6-inh | 0.962 |
CYP2d6-sub | 0.93 |
CYP3a4-inh | 0.684 |
CYP3a4-sub | 0.445 |
CL | 12.66 |
T12 | 0.846 |
hERG | 0.103 |
Ames | 0.202 |
ROA | 0.096 |
SkinSen | 0.948 |
Carcinogencity | 0.142 |
EI | 0.98 |
Respiratory | 0.259 |
NR-Aromatase | 0.765 |
Antiviral | No |
Prediction | 0.631637 |